# OnCo record methoxsalen-ecp (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/methoxsalen-ecp/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "methoxsalen-ecp" ;
  schema:name "Methoxsalen (extracorporeal photopheresis)"@en ;
  schema:alternateName "8-Methoxypsoralen"@en, "8-MOP"@en, "Uvadex" ;
  schema:description "Uvadex is the drug used in photopheresis, where a patient's white cells are drawn off, treated with methoxsalen and ultraviolet light, and returned; it is approved for the skin symptoms of cutaneous T-cell lymphoma and widely used for graft-versus-host disease."@en ;
  schema:url <https://onco.cc/drugs/methoxsalen-ecp/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Extracorporeal_photopheresis> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=uvadex>, <https://en.wikipedia.org/wiki/Extracorporeal_photopheresis> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Psoralen photosensitiser used with ultraviolet A on white cells outside the body" ;
  onco:approval "US 1999: Palliative treatment of skin manifestations of cutaneous T-cell lymphoma unresponsive to other therapy, by extracorporeal photopheresis" ;
  onco:cancers <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/gvhd-photopheresis/> ;
  onco:terms <https://onco.cc/terms/gvhd/> ;
  onco:trials <https://onco.cc/trials/nct01686594/>, <https://onco.cc/trials/nct04930653/>, <https://onco.cc/trials/nct07619898/> .